Long-term (104-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)

dc.contributor.author	Gómez-Reino Carnota, Juan Jesús
dc.date.accessioned	2017-06-07T07:10:41Z
dc.date.available	2017-06-07T07:10:41Z
dc.date.issued	2015
dc.identifier.issn	0315-162X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/3490
dc.language.iso	eng
dc.title	Long-term (104-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)
dc.type	Publicación de congreso
dc.authorsophos	Gladman, D
dc.authorsophos	Kavanaugh, A
dc.authorsophos	Mease, P
dc.authorsophos	Adebajo, A
dc.authorsophos	Gomez-Reino, J
dc.authorsophos	Hall, S
dc.authorsophos	Lespessailles, E
dc.authorsophos	Schett, G
dc.authorsophos	Shah, K
dc.authorsophos	Hu, CC
dc.authorsophos	Stevens, R
dc.authorsophos	Wollenhaupt, J
dc.identifier.isi	357280700088
dc.identifier.sophos	18861
dc.issue.number	7
dc.journal.title	JOURNAL OF RHEUMATOLOGY
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Reumatoloxía
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	42

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.